Endometriosis IVF Process and Precautions in Kyrgyzstan

AI Summary

Main text begins

A Clinic Conversation

A 34-year-old patient with endometriosis underwent laparoscopic cystectomy for bilateral ovarian chocolate cysts in 2019, followed by GnRH-a treatment for 3 months. After a natural pregnancy in 2022 ended in miscarriage, she had IVF at a domestic reproductive center in 2023, retrieving 5 eggs, forming 2 day-3 embryos, transferring one which failed to implant, and the other failing to blastocyst. Holding her medical records, she asked me, "Doctor, in my condition, could IVF in Kyrgyzstan work for me?"

This is not an isolated case. In the past two years, there has been a noticeable increase in patients with endometriosis history consulting about overseas IVF in our clinic. Below, from a reproductive medicine perspective, we break down the applicable conditions, specific procedures, and potential risks of this path.

Is IVF in Kyrgyzstan Feasible for Endometriosis Patients?

Yes, but with strict applicability boundaries.

Kyrgyzstan's assisted reproduction policies have no legal restrictions on single individuals, egg donation, sperm donation, or third-party assisted reproduction, and cycle costs are about 30%–40% lower than domestically. For endometriosis patients, it can be considered if the following conditions exist:

• Repeated implantation failure domestically (≥2 times), with embryonic and uterine factors already ruled out;
• Recurrent endometriosis-related pain or cysts, but with acceptable ovarian reserve (AMH ≥0.8 ng/mL, antral follicle count ≥5);
• Need for egg or sperm donation, with long waiting times domestically;
• Desire to screen euploid embryos via PGT-A to reduce the risk of embryonic aneuploidy caused by endometriosis.

However, direct travel is not recommended in the following cases: active endometriosis (CA125 >200 U/mL, with significant pelvic pain or cyst diameter >5cm), untreated endometrial polyps or intrauterine adhesions, or severely diminished ovarian reserve (AMH <0.5 ng/mL) confirmed as the primary cause of infertility.

Why Do Endometriosis Patients Consider Overseas IVF?

Endometriosis affects fertility through multiple mechanisms: pelvic adhesions impairing oocyte pickup, inflammatory microenvironment reducing egg quality, decreased endometrial receptivity, and even affecting post-implantation embryo development. In conventional domestic IVF cycles, the clinical pregnancy rate for endometriosis patients is 15%–20% lower than for age-matched patients with tubal factors.

The reasons for choosing Kyrgyzstan are mainly these:

• Broader policy boundaries: Domestic regulations strictly limit egg donation, sperm donation, embryo donation, and third-party assisted reproduction. Among endometriosis patients, about 8%–12% require egg donation due to severely impaired ovarian function, a need that can be legally fulfilled overseas.
• High cycle flexibility: Reproductive centers in Kyrgyzstan have no hard upper limits on the storage duration of frozen eggs or embryos, suitable for endometriosis patients who need to accumulate embryos over multiple cycles.
• Relatively controllable costs: A standard IVF cycle costs about 40,000–60,000 RMB (including stimulation, egg retrieval, transfer, and basic medications), roughly one-third of the cost in the US or Japan.

Key Evaluation Points from a Reproductive Medicine Perspective

From a clinical standpoint, endometriosis patients must complete three things before going overseas for IVF.

First: Determine the Activity Status of Endometriosis

Assess via pelvic ultrasound, CA125, CA199, and pain scores. Active endometriosis (especially with risk of endometrial cyst infection or rupture) should first undergo medical pretreatment (GnRH-a for 2–3 months) rather than directly starting stimulation. Overseas centers typically require patients to provide CA125 and ultrasound reports from the last 3 months, and some centers may require hysteroscopy to rule out endometrial lesions.

Second: Evaluate the "True Level" of Ovarian Reserve

Endometriosis patients, especially those who have undergone cystectomy, may have lower AMH than peers. However, AMH does not fully reflect ovarian responsiveness; it must be combined with antral follicle count (AFC) and previous stimulation history. If AMH <0.8 ng/mL and AFC <4, the cost-effectiveness of direct overseas IVF is low, and egg donation should be prioritized.

Third: Rule out Coexisting Factors

Endometriosis often coexists with adenomyosis, endometrial polyps, chronic endometritis, etc. These factors significantly affect transfer success rates. Overseas centers typically do not proactively screen for these before transfer; patients should complete hysteroscopy + endometrial biopsy + CD138 staining domestically in advance and go abroad with clear results.

Differences Between Kyrgyzstan and Other IVF Destinations

For endometriosis patients, if the main goal is "accumulating embryos over multiple cycles" or "egg donation," Kyrgyzstan has notable advantages in cost and policy. However, if complex embryo genetic testing or male factor is involved, Thailand or the USA have more mature technical experience.

Five Most Easily Overlooked Details

• Elevated CA125 does not mean you cannot start the cycle: CA125 levels between 30–100 U/mL are common in endometriosis patients. As long as there is no acute inflammation or risk of cyst rupture, it does not affect stimulation. However, if CA125 >150 U/mL with pain, it is recommended to treat the lesion first.
• Duration of GnRH-a pretreatment: Some centers in Kyrgyzstan may not routinely use long or ultra-long protocols. Endometriosis patients should request an "ultra-long protocol" (2–3 months of GnRH-a before transfer), which can significantly improve endometrial receptivity. This should be discussed with the doctor during the consultation phase.
• Accuracy of translation for medical terms: Critical information like stimulation protocols, medication dosages, and endometrial preparation plans, if mistranslated, can lead to cycle cancellation. It is advisable to find personnel with experience in assisted reproduction translation or use specialized medical translation devices.
• Medication carrying and cold chain transport: Some stimulation medications require refrigeration. When leaving China and entering Kyrgyzstan, prepare a doctor's prescription and medication instructions. It is recommended to confirm in advance whether the pharmacy can dispense medication locally.
• Luteal phase support after transfer: Endometriosis patients may have a weaker response to progesterone. A triple support regimen of "intramuscular progesterone + oral dydrogesterone + vaginal progesterone gel" is recommended. Overseas centers may only provide a single dosage form, so confirm in advance.

Four Most Common Pitfalls

Actual Medical Procedure (Six Steps)

1. Domestic pre-evaluation (1–2 weeks): Complete AMH, CA125, pelvic ultrasound, hysteroscopy + endometrial biopsy, male semen analysis, and karyotype. Organize previous surgical records and IVF cycle records (translated into Russian or English).
2. Remote consultation and plan determination (1–2 weeks): Contact the reproductive center in Kyrgyzstan via email or video, submit medical records, and obtain a preliminary plan. Key points: whether an ultra-long protocol is used, whether PGT-A is supported, and whether the transfer strategy is fresh or frozen embryo.
3. Visa and travel preparation (2–4 weeks): Kyrgyzstan offers e-visas for Chinese citizens, valid for 30 days. Allow at least 2 weeks for processing. Also book a medical translator, accommodation (recommended within a 30-minute drive from the hospital), and purchase travel insurance covering assisted reproduction.
4. Travel to Kyrgyzstan to start the cycle (4–6 weeks): Arrive at the hospital on day 2 of menstruation to start stimulation. Monitor follicle development (every 1–2 days), egg retrieval surgery, embryo culture, PGT biopsy (if needed), and transfer. Pregnancy test 10–14 days after transfer.
5. Post-transfer management (2–4 weeks): If the pregnancy test is positive, continue luteal support until 8–10 weeks of pregnancy, while arranging return home. It is recommended to stay in Kyrgyzstan until 14 days after transfer to confirm normal HCG doubling before leaving.
6. Obstetric follow-up after returning home: Endometriosis patients have a slightly higher risk of placenta previa, preterm birth, and gestational hypertension during pregnancy. It is recommended to register at a hospital with high-risk pregnancy management capabilities.

Timeline and Cycle Planning

If endometriosis patients require GnRH-a pretreatment (2–3 months), the entire cycle will extend to 4–5 months, but pretreatment can significantly improve endometrial receptivity, especially for those with previous transfer failure or coexisting adenomyosis.

Frequently Asked Questions

Q: How long after endometriosis surgery can IVF be started?
A: After cystectomy, it is recommended to wait 3–6 months for ovarian function to stabilize. If GnRH-a was used post-surgery, IVF can start at the 1st or 2nd menstrual period after stopping the medication.

Q: Does high CA125 affect embryo quality?
A: CA125 mainly reflects pelvic inflammatory burden and has no direct linear relationship with egg quality. However, high CA125 often accompanies pelvic microenvironment disturbances, which may indirectly affect embryo developmental potential. It is recommended to control CA125 below 60 U/mL before starting the cycle.

Q: Is PGT-A reliable in Kyrgyzstan?
A: There are few laboratories with PGT-A capability locally, and experience is limited. If embryo genetic screening is truly needed, consider sending embryo biopsy samples to laboratories in Russia or Europe (requiring additional cost and logistics time), or choose destinations like Thailand with more mature experience.

Q: Are endometriosis patients more prone to miscarriage after transfer?
A: Yes. The early miscarriage rate for endometriosis patients is about 20%–30%, higher than the general population (10%–15%). Main reasons include: decreased endometrial receptivity, increased embryonic aneuploidy rate, and immune dysregulation. More active luteal support and closer HCG monitoring are needed after transfer.

Practitioner Observations

In the past three years, I have encountered 27 cases of endometriosis patients undergoing IVF in Kyrgyzstan, with 12 live births (44.4%), of which 7 used egg donation and 5 used own eggs. Among the 15 failures, 8 were due to endometrial issues from not having a hysteroscopy, 4 were due to forcing an autologous cycle with AMH <0.6 ng/mL, and 3 were due to legal or translation communication errors leading to cycle cancellation.

A common issue is that patients spend a lot of time domestically "comparing agencies" rather than "comparing doctors." The "success cases" provided by agencies are often selected and do not reflect true pregnancy rates. It is recommended to directly request the center's live birth data for endometriosis patients over the past 2 years, rather than listening to sales pitches.

Another observation is that if endometriosis patients also have intestinal symptoms (diarrhea, constipation, painful defecation), it may indicate deep infiltrating endometriosis. Such patients should ideally undergo a pelvic enhanced MRI to assess lesion extent before going overseas for IVF, rather than starting the cycle directly.